Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Findings Should Enhance Treatments for Stopping Immune System Attacks

May 15, 2015 9:12 am | by University of Manchester | News | Comments

Scientists have made an important discovery about an immune cell which is already being used in immunotherapy to treat diseases such as type I diabetes. Read more...

TOPICS:

Scientists Discover Bacterial Cause Behind Fatal Heart Complications

May 15, 2015 9:06 am | by University of Liverpool | News | Comments

Researchers discover a key cause of life threatening heart complications, conditions that frequently follow severe infections with the bacteria responsible for pneumonia and meningitis. Read more...

TOPICS:

Smoking Induces Early Signs of Cancer in Cheek Swabs

May 15, 2015 8:59 am | by University College London | News | Comments

The study provides evidence that smoking induces a general cancer program that is also present in cancers which are not usually associated with it – including breast and gynecological cancers. Read more...

TOPICS:
Advertisement

New Study Eases Fear of Airborne Ebola

May 15, 2015 8:52 am | by University of Florida | News | Comments

At the peak of the Ebola epidemic last fall came a frightening new possibility: a mutation that could allow the disease to spread through the air. Read more...

TOPICS:

Fibromyalgia Treatment Market Value Will Crawl to $1.9B by 2023

May 15, 2015 8:47 am | by Maura Musciacco, MSc, GlobalData's Director or Neurology and Opthalmology | Articles | Comments

The company’s latest report states that while this growth will be primarily driven by the potential introduction of four late-stage pipeline agents. Read more...

TOPICS:

Signaling Pathway Revealed Through Which a Promising Anti-Leukemia Drug Kills Cancer Cells

May 14, 2015 1:01 pm | News | Comments

Inhibiting a protein called BRD4 critical to the survival of acute myeloid leukemia (AML) cells has shown to be an effective therapeutic strategy. However, the mechanism that explains how the protein works has remained a mystery. Now, scientists at Cold Spring Harbor Laboratory (CSHL) have discovered the larger cancer-causing pathway that the protein fits into. Read more...

TOPICS:

ANI Pharmaceuticals Acquires Rights to Testosterone Gel 1%

May 14, 2015 12:50 pm | News | Comments

ANI Pharmaceuticals, Inc. today announced that it has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals. Read more...

TOPICS:

AcelRx Awarded Contract to Advance ARX-04

May 14, 2015 12:44 pm | News | Comments

AcelRx Pharmaceuticals, Inc. , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today announced it has entered into Contract No. W81XWH-15-C-0046 worth up to $17.0 million, supported by the United States Army Medical Research and Materiel Command (USAMRMC) within the U.S. Department of Defense (DoD). Read more...

TOPICS:
Advertisement

New Insight into Inflammatory Bowel Disease May Lead to Better Treatments

May 14, 2015 12:37 pm | by Washington University in St. Louis | News | Comments

Inflammatory bowel disease (IBD) afflicts 1.6 million people in the United States, causing abdominal pain, diarrhea, constipation, rectal bleeding and other potentially debilitating symptoms. Read more...

TOPICS:

Cancer Institute of NJ Investigates Promising Immunotherapy for Toughest Lung Cancers

May 14, 2015 11:47 am | by Seth Augenstein, Digital Reporter | Articles | Comments

Small-cell lung cancer, often caused by smoking, is among the most stubborn diseases in oncology. While it might respond initially to chemotherapy, it often recurs – and comes back even more resistant to treatment. But a new use of a known immunotherapy, bolstering the body’s immune system, is showing some promise against this disease, according to research taking place at the Rutgers Cancer Institute of New Jersey. Read more...

TOPICS:

B Vitamin May Prevent Recurrence of Skin Cancers

May 14, 2015 11:33 am | by Ryan Bushey, Associate Editor | Articles | Comments

A study conducted by scientists at Australia’s University of Sydney found that a form of vitamin B3 has the potential to lower the chance of developing skin cancer. Read more...

TOPICS:

Bovine TB Infection Depends on Feedback Between Cattle, Badgers

May 14, 2015 9:22 am | by University of Bristol | News | Comments

New research has found that BTB is most likely to be nearly under control in both species taken in isolation, however together, control is likely to be considerably more challenging. Read more...

TOPICS:

Damming and Damning Hemorrhagic Fever

May 14, 2015 9:17 am | by University of Montreal | News | Comments

A potential mechanism to combat diseases caused by hemorrhagic fever viruses has been discovered. Read more...

TOPICS:

Breakthrough Opens Door to Safer Lupus Drugs

May 14, 2015 9:08 am | by Monash University | News | Comments

Researchers could revolutionize treatments given to lupus sufferers, saving thousands of people each year from serious illness or death caused by secondary infections. Read more...

TOPICS:

Roche Announces Phase 2 Study Results for Lung Cancer Immunotherapy

May 14, 2015 9:04 am | News | Comments

Roche announced interim results from a global, randomized Phase 2 study in people with previously treated NSCLC.  Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading